| For: | Jiao HY, Yan XM, Li JX, Zhang ZG. Combination therapy reduces transarterial chemoembolization resistance in advanced hepatocellular carcinoma. World J Clin Oncol 2025; 16(8): 109419 [PMID: 40901309 DOI: 10.5306/wjco.v16.i8.109419] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i8/109419.htm |
| Number | Citing Articles |
| 1 |
Thomas Eggleston, Fady Bassem Fayek, Jacqueline Kowalke, Mina S. Makary. Locoregional Therapy Pressure-Enabled Drug Delivery for Liver Cancers. Cancers 2026; 18(15) doi: 10.3390/cancers18152367
|
| 2 |
Liyang Yang, Disi Liu, Shanshan Yang, Jiewen Chen, Ge Wen. Preoperative Prediction of TACE Refractoriness in Hepatocellular Carcinoma Using CT-Based Radiomics Model. Journal of Hepatocellular Carcinoma 2026; doi: 10.2147/JHC.S587246
|
| 3 |
Su-Ming Shi, Qing-Qing Zhou, Yi-Meng Ren, Teng-Fei Liu. Breaking through the transarterial chemoembolization resistance barrier: Reshaping the treatment path for advanced liver cancer with triple therapy. World Journal of Clinical Oncology 2025; 16(11): 112404 doi: 10.5306/wjco.v16.i11.112404
|
| 4 |
Yong Kuang, Kai Hu, Hongya Zhu, Ruying Lin, Dehao Wang, Yuehan Huang, Weijie Yuan, Jingyao Chen, Yazhou Sun, Jiahao Feng. Opportunities and challenges of dihydrodiol dehydrogenase expression in hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2026; 225 doi: 10.1016/j.critrevonc.2026.105462
|